Enhancing therapies for MYC-overexpressing Non-Hodgkin's lymphoma: A role for MYC downregulation and new combination therapies

被引：0
|
作者：
Psaras, Alexandra Maria [1 ]
Brooks, Tracy Ann [1 ]
机构：
[1] Binghamton Univ, Johnson City, TN USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-653
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
653
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting the B-cell receptor pathway: a review of current and future therapies for non-Hodgkin's lymphoma
    Rodgers, Thomas D.
    Reagan, Patrick M.
    EXPERT OPINION ON EMERGING DRUGS, 2018, 23 (02) : 111 - 122
  • [42] New monoclonal antibodies for non-Hodgkin's lymphoma
    Leonard, J. P.
    Martin, P.
    Ruan, J.
    Elstrom, R.
    Barrientos, J.
    Coleman, M.
    Furman, R. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 60 - 62
  • [43] New developments in immunotherapy for non-Hodgkin's lymphoma
    Leonard J.P.
    Furman R.R.
    Ruan J.
    Coleman M.
    Current Oncology Reports, 2005, 7 (5) : 364 - 371
  • [44] New agents in development for non-Hodgkin's lymphoma
    Leonard, John P.
    Ruan, Jia
    Martin, Peter
    Coleman, Morton
    Furman, Richard R.
    SEMINARS IN HEMATOLOGY, 2007, 44 (03) : S18 - S21
  • [45] New directions in radiommunotherapy of non-Hodgkin's lymphoma
    DeNardo, GL
    CLINICAL LYMPHOMA, 2004, 5 : S4 - S4
  • [46] Non-Hodgkin's-Lymphoma Proven and New
    Truemper, L.
    Hoeffken, K.
    ONKOLOGE, 2015, 21 (10): : 894 - +
  • [47] Association between C-myc and K-ras gene polymorphisms and non-Hodgkin lymphoma
    Liu, Q. -H.
    Li, X. -D.
    Song, M. -Y.
    Ran, R. -N.
    Wu, Z. -S.
    Yang, B. -X.
    Wang, H.
    Xia, R. -X.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4396 - 4403
  • [48] Novel therapies for peripheral T-cell non-Hodgkin's lymphomas
    Cheson, Bruce D.
    CURRENT OPINION IN HEMATOLOGY, 2009, 16 (04) : 299 - 305
  • [49] Repetitive Low-Dose Radiation Therapies As an Alternative Option for Indolent Non-Hodgkin Lymphoma
    Saleh, Khalil
    Michot, Jean-Marie
    Danu, Alina
    Lazarovici, Julien
    Khalife-Saleh, Nadine
    Ghez, David
    Chahine, Claude
    Dakdouki, Yolla
    Fahri, Jonathan
    Willekens, Christophe
    Boros, Angela
    Arfi-Rouche, Julia
    Maroun, Pierre
    Deutsch, Eric
    Ribrag, Vincent
    Mazeron, Renaud
    BLOOD, 2016, 128 (22)
  • [50] Preclinical activity in non-Hodgkin's lymphoma of Selinexor, a selective inhibitor of nuclear export (SINE), is enhanced through combination with standard-of-care therapies
    Azmi, Asfar S.
    Aboukameel, Amro
    Carlson, Robert O.
    Elloul, Sivan
    Shacham, Sharon
    Kauffman, Michael
    Frenkel, Ran
    Mohammad, Ramzi M.
    CANCER RESEARCH, 2015, 75
12345